Repair Biotechnologies, Inc. filed a Form D with the Securities and Exchange Commission on 2025-11-25.
Repair Biotechnologies, Inc. filed a Form D notice of an exempt securities offering with the SEC on November 25, 2025. The filing reports $5.26M sold. Its industry group is Biotechnology. It names Reason (CEO's full legal name is "Reason"), Guilherme Cherman Perdigao de Oliveira (Executive Officer, Director), Kelsey Moody (Director) (SEC Form D, November 25, 2025).
Is this your company?
Sell to companies like Repair Biotechnologies, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-11-25 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Repair Biotechnologies, Inc.
Free to see. No signup.
More on the people and the money behind Repair Biotechnologies, Inc., from the filings we hold.
Biotechnology raises by companies based in New York, filed within 90 days of this one, largest first.
Get an email when Repair Biotechnologies, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Repair Biotechnologies, Inc. raises, hires or launches. No email unless you switch it on.
Watch Repair Biotechnologies, Inc. →Get the full cited report on Repair Biotechnologies, Inc.
What the filing shows about Repair Biotechnologies, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Repair Biotechnologies, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Repair Biotechnologies, Inc.'s address as 841 E Fayette Street, Syracuse, NY 13210.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Repair Biotechnologies, Inc. See pricing
Repair Biotechnologies, Inc. is a registered filer with the SEC (CIK 1750699) and has filed since 2023-06-16. 3 filings are on record, the latest on 2025-11-25.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Repair Biotechnologies, Inc.'s Form D of 2025-11-25 names Reason, Guilherme Cherman Perdigao de Oliveira and Kelsey Moody as its officers, directors or promoters.
Its new offerings report $19.82M sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 764 filings in Biotechnology, totalled by week. The dot is this raise, $5.26M, on the same scale — one filing against the whole group's total, so it sits low by construction.
On the filing as: Executive Officer, Director.
Reason is named as Ceo's full legal name is "Reason" on the Form D that Repair Biotechnologies, Inc. filed with the SEC on 25 November 2025, one of 3 people that filing names.
Guilherme Cherman Perdigao de Oliveira is named as Executive Officer and Director on the Form D that Repair Biotechnologies, Inc. filed with the SEC on 25 November 2025, one of 3 people that filing names.
Kelsey Moody is named as Director on the Form D that Repair Biotechnologies, Inc. filed with the SEC on 25 November 2025, one of 3 people that filing names.
3 people named on the filing — 2 holding an executive role and 1 as a director only.
Named as of the 2025-11-25 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Repair Biotechnologies, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Repair Biotechnologies, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Repair Biotechnologies, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Repair Biotechnologies, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Repair Biotechnologies, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Repair Biotechnologies, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/repair-biotechnologies-inc-form-d-25000001